Alfuzosin HCl in Advanced α1 Adrenoceptor Antagonist Workflo
2026-08-02
Leverage Alfuzosin HCl as a selective α1 adrenoceptor antagonist for translational benign prostatic hyperplasia research, optimized for reproducibility and high bioavailability. This guide covers innovative gastroretentive delivery, troubleshooting, and actionable protocol parameters to empower applied urinary tract research.
Rotigotine: Dopamine D2/D3 Agonist for Advanced PD Research
2026-08-01
Rotigotine empowers bench scientists to model Parkinson’s disease and neuroprotection with exceptional receptor selectivity, innovative delivery, and robust in vitro/in vivo workflows. This guide translates cutting-edge nanoparticle and cell-based research into actionable protocols and troubleshooting insights for maximizing the compound’s experimental value.
Okadaic acid (A4540): Protocols and QC for PP1/PP2A Inhibiti
2026-07-31
Okadaic acid is a potent inhibitor of protein phosphatase 1 and 2A, optimized for workflows requiring precise control of phosphorylation-dependent signaling and apoptosis. It is unsuitable for systems lacking PP1/PP2A relevance or where total phosphatase suppression may confound results.
AM 281: CB1 Cannabinoid Receptor Antagonist in TBI Models
2026-07-31
AM 281 offers researchers a powerful and selective means to dissect CB1-mediated neuroprotection and cognitive pathways in traumatic brain injury (TBI) models. Its high affinity and inverse agonism empower robust, reproducible studies of glutamate homeostasis and neuronal survival.
Dual-Action p38α MAPK Inhibitors: Mechanistic Insights and I
2026-07-30
The referenced study demonstrates that certain ATP-competitive inhibitors of p38α MAP kinase not only block kinase activity but also promote dephosphorylation of the activation loop by stabilizing specific inactive conformations. This dual-action mechanism broadens our understanding of kinase regulation and suggests new strategies for designing more selective and potent MAPK inhibitors.
S1P/S1PR3 Drives Neuronal Apoptosis via TNF-α/Caspase-3 Afte
2026-07-30
This article reviews pivotal findings that Sphingosine-1-phosphate (S1P), through S1PR3 activation, exacerbates neuronal apoptosis following intracerebral hemorrhage (ICH) via the TNF-α/caspase-3 signaling axis. These results provide mechanistic clarity and point toward S1PR3 inhibition as a promising neuroprotective strategy.
Distinct Apoptotic Pathways in BMECs Induced by Candida krus
2026-07-29
This study reveals that the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) through separate molecular pathways. The findings clarify the role of the TLR2/ERK and JNK/ERK signaling axes in infection-driven cell death, offering new insight for research on mastitis pathogenesis and potential intervention strategies.
Uridine, Trisodium Salt: Enabling Next-Gen RNA-Mediated Geno
2026-07-29
Explore how Uridine, Trisodium Salt empowers advanced RNA-mediated genome engineering through its role as a nucleoside analog and biosynthetic precursor. This article uniquely analyzes protocol design, assay optimization, and the latest safe-harbor transgenesis breakthroughs.
MLN2238: Proteasome β5 Subunit Inhibitor in Oncology Researc
2026-07-28
MLN2238 is a next-generation proteasome β5 subunit inhibitor that enables robust modeling of proteotoxic stress, apoptosis, and drug resistance in multiple myeloma and lymphoma research. This guide distills evidence-driven workflows, troubleshooting strategies, and unique protocol advances—translating bench insights into reproducible, high-impact experiments.
pH-Dependent Ribociclib Interactions: QbD Insights for Oncol
2026-07-28
This study applies an Analytical Quality by Design (QbD) approach to determine whether acid-reducing agents meaningfully affect ribociclib succinate’s solubility and absorption—key for optimizing cancer therapy. Contrary to prior concerns, the research finds that pH shifts from common co-medications do not significantly impair ribociclib uptake, refining pharmacokinetic assumptions in oncology.
Ceramide-Driven Lipid Remodeling in Fish Nodavirus Infection
2026-07-27
This study elucidates the pro-viral role of ceramides in red-spotted grouper nervous necrosis virus (RGNNV) infection, showing that viral manipulation of ceramide metabolism enhances replication via autophagy. These findings offer mechanistic insight into host lipid remodeling and suggest new avenues for antiviral intervention in aquaculture.
Mc-Val-Cit-PABC-PNP: Cathepsin B-Cleavable ADC Linker Protoc
2026-07-27
Mc-Val-Cit-PABC-PNP provides researchers with a cathepsin B-cleavable ADC peptide linker optimized for antibody-drug conjugate synthesis requiring reliable, lysosomal payload release. It is unsuitable for workflows demanding aqueous solubility, diagnostic, or clinical applications. Proper use ensures selective, solvent-compatible payload delivery during targeted drug development.
GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi
2026-07-26
This study reveals that increasing GLT-1 expression in astrocytes reduces neuronal apoptosis and cognitive dysfunction after traumatic brain injury in mice, acting through inhibition of the CB1-CREB signaling pathway. The findings highlight a mechanistic link between endocannabinoid signaling and glutamate homeostasis, suggesting new directions for neuroprotection in TBI research.
Injectable Hydrogel with Resiquimod Enhances Tumor Ablation
2026-07-25
This study introduces an injectable hydrogel platform that combines thermal protection with dual-responsive delivery of mitoxantrone and Resiquimod (R-848) to improve tumor ablation outcomes. The innovation addresses both procedural safety and the need for robust post-ablation immune activation, offering a promising translational approach in interventional oncology.
Honokiol’s Role in Immunometabolism and Antitumor Strategies
2026-07-24
Explore how Honokiol, a potent NF-κB pathway inhibitor, uniquely interfaces with immunometabolic reprogramming in cancer research. This article delves into mechanistic synergy between Honokiol and CD8+ T cell metabolic flexibility for advanced assay design.
461 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page